Pooling data from the studies mentioned above on the proportions in each RASopathy exceeding the SCQ/M‐CHAT cut‐off, and calculating 95% confidence intervals (95%CI) based on a binomial distribution, we found that 11% of NF1 participants (95%CI 3.45;18.55) screened positive. This evidence concerns the gene NF1 and RASopathy.